Crossmark

Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients

Crossref DOI link: https://doi.org/10.1016/j.aohep.2020.04.002

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kikukawa, Kanako

Uchida-Kobayashi, Sawako

Tamori, Akihiro

Yoshida, Kanako

Kotani, Kohei

Motoyama, Hiroyuki

Kozuka, Ritsuzo

Hagihara, Atsushi

Fujii, Hideki

Morikawa, Hiroyasu

Enomoto, Masaru

Murakami, Yoshiki

Kawada, Norifumi
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (19fk0210058h0001)
License Information

Text and Data Mining valid from 2020-07-01

Version of Record valid from 2020-05-05
More Information

This article is maintained by: Elsevier

Article Title: Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2020.04.002

Content Type: article

Copyright: © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below